Volume 28, Number 8—August 2022
Imported Monkeypox from International Traveler, Maryland, USA, 2021
To the Editor: Costello et al. described a patient in Maryland, USA, with a diffuse vesicular rash initially diagnosed as disseminated varicella zoster virus (VZV) infection. Only after a biopsy revealed unexpected findings was monkeypox suspected (1). Monkeypox is commonly confused with VZV in countries where both infections are endemic. High fever, lymphadenopathy, and a deep-seated, well-circumscribed, umbilicated rash in the same stage of development (i.e., macule, papule, vesicle, or scab) in distinct anatomic locations are characteristic of monkeypox (2). Although the patient in Maryland experienced lymphadenopathy and rash with umbilicated lesions suggestive of monkeypox, he was afebrile, denied other prodromal signs and symptoms (e.g., headache and chills) that typically precede monkeypox rash, and improved while receiving intravenous acyclovir, features more consistent with VZV. However, the unusual clinical signs and symptoms experienced by this patient were similar to those observed in other patients in the evolving 2022 multinational monkeypox response.
Because differential diagnosis can be challenging, public health authorities should be consulted promptly when monkeypox is possible. US Laboratory Response Network laboratories (https://emergency.cdc.gov/lrn) can enable rapid testing of specimens (e.g., lesions swab), and pathogen-specific antiviral medications can be acquired through consultation with the Centers for Disease Control and Prevention. Public health investigation for a single case of monkeypox can be intensive and complicated; case-patient contacts outside of the hospital must be identified, monitored, and potentially given 1 of the 2 orthopoxvirus vaccines offered for postexposure prophylaxis in the United States (3–5).
Factors that should raise suspicion for monkeypox in a patient with related signs and symptoms include history of travel outside of the United States to a country with confirmed cases or where monkeypox virus is endemic, contact with a person with a similar-appearing rash or who has received a diagnosis of confirmed or probable monkeypox, contact with Africa-endemic wild animal or pet species (living or dead), or use of a product derived from those animals (e.g., game meat, creams, lotions, powders). Monkeypox should also be considered in patients with close or intimate contact with persons in social networks experiencing high monkeypox activity, including men who have sex with men who meet partners through a website, digital application, or social event. Prompt consultation with public health authorities is essential for providing clinical guidance, expediting testing and treatment, and preventing secondary cases (3).
- Costello V, Sowash M, Gaur A, Cardis M, Pasieka H, Wortmann G, et al. Imported monkeypox from international traveler, Maryland, USA, 2021. Emerg Infect Dis. 2022;28:1002–5. DOIPubMedGoogle Scholar
- Osadebe L, Hughes CM, Shongo Lushima R, Kabamba J, Nguete B, Malekani J, et al. Enhancing case definitions for surveillance of human monkeypox in the Democratic Republic of Congo. PLoS Negl Trop Dis. 2017;11:
e0005857. DOIPubMedGoogle Scholar
- Rao AK, Schulte J, Chen T-H, Hughes CM, Davidson W, Neff JM, et al.; July 2021 Monkeypox Response Team. Monkeypox in a traveler returning from Nigeria—Dallas, Texas, July 2021. MMWR Morb Mortal Wkly Rep. 2022;71:509–16. DOIPubMedGoogle Scholar
- Petersen BW, Damon IK, Pertowski CA, Meaney-Delman D, Guarnizo JT, Beigi RH, et al. Clinical guidance for smallpox vaccine use in a postevent vaccination program. MMWR Recomm Rep. 2015;64(RR-02):1–26.PubMedGoogle Scholar
- Rao AK, Petersen BW, Whitehill F, Razeq JH, Isaacs SN, Merchlinsky MJ, et al. Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices—United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:734–42. DOIPubMedGoogle Scholar
Original Publication Date: July 07, 2022
Table of Contents – Volume 28, Number 8—August 2022
|EID Search Options|
|Advanced Article Search – Search articles by author and/or keyword.|
|Articles by Country Search – Search articles by the topic country.|
|Article Type Search – Search articles by article type and issue.|
Please use the form below to submit correspondence to the authors or contact them at the following address:
Faisal Syed Minhaj, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop 24-12, Atlanta, GA 30327-4027, USA